Education
About Us
Working with TipRanks
Follow Us
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (DE:JIL)
FRANKFURT:JIL
JIL Stock Chart & Stats
€0.23
--
Market closed
€0.23
--
Day’s Range― - ―
52-Week Range€0.03 - €0.24
Previous CloseN/A
VolumeN/A
Average Volume (3M)166.00
Market Cap
€123.71M
Enterprise Value€605.53M
Total Cash (Recent Filing)€748.30M
Total Debt (Recent Filing)€72.40M
Price to Earnings (P/E)5.0
Beta580.01
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding172,500,000
10 Day Avg. Volume0
30 Day Avg. Volume166
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)0.45
Price to Sales (P/S)0.82
P/FCF Ratio3.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JIL FAQ
What was Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price range in the past 12 months?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H lowest stock price was €0.03 and its highest was €0.24 in the past 12 months.
What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap is €123.71M.
When is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 41 days.
How were Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s earnings last quarter?
Currently, no data Available
Is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H overvalued?
According to Wall Street analysts Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price is currently Overvalued.
Does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pay dividends?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H does not currently pay dividends.
What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H have?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 172,500,000 shares outstanding.
What happened to Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H?
Currently, no hedge funds are holding shares in DE:JIL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H
Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (JIL) Earnings & Revenues
Technical Analysis
Lee's Pharmaceutical Holdings Limited
―
Fusen Pharmaceutical Co., Ltd.
―
JBM (Healthcare) Ltd.
―
Dawnrays Pharmaceutical Holdings Ltd.
―
Zhongzhi Pharmaceutical Holdings Limited
―